IL-6 Inhibitor for UC Shows Some Promise in Mid-Stage Trial
Induction therapy with a novel interleukin 6 (IL-6) inhibitor for active ulcerative colitis…
Browsing Tag
IL6
Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritis
A new type of anti-interleukin-6 (IL-6) biologic called olokizumab was as effective as adalimumab…
Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in…
ACTON, Mass., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on developing cost-effective,…
Targeting interleukin-6 could help relieve immunotherapy side effects: Study shows…
Researchers at The University of Texas MD Anderson Cancer Center have identified a novel strategy to reduce immune-related adverse events from immunotherapy treatment by targeting the…
FDA Authorizes IL-6 Inhibitor for Severe COVID-19 Patients
Tocilizumab (Actemra), an interleukin-6 (IL-6) inhibitor, was authorized to treat certain…